Top Industry Leaders in the Tonsil Cancer Market
Latest Tonsil Cancer Companies Update:
AstraZeneca Their anti-PD-1 immunotherapy drug, Imfinzi (durvalumab), received FDA approval for recurrent/metastatic head and neck squamous cell carcinoma, potentially providing a new treatment option for tonsil cancer patients.
Merck & Co.Their anti-PD-1 therapy, Keytruda (pembrolizumab), demonstrated promising results in clinical trials for advanced head and neck cancers, including tonsil cancer.
Medtronic Introduced their Hugo RAS robotic surgery system, offering potential for minimally invasive tonsillectomies in appropriate cases, reducing surgical risks and recovery times.
List of Tonsil Cancer Key companies in the market
- F. Hoffmann-La Roche Ltd (Switzerland),
- Amgen Inc. (US),
- Novartis AG(Switzerland),
- Abbott (US),
- Beckman Coulter Inc. (US),
- Debiopharm Group (Switzerland),
- AbbVie Inc. (US),
- Bayer AG (Germany)